Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacometabolomics of Andrographis Paniculata and Metformin
NCT04161404Phase 1Unknown
- Sponsor
- Universiti Malaya
- Start
- Aug 2019
- Primary completion
- Dec 2019
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of andrographis paniculata in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Universiti Malaya. Primary endpoints: Area under the plasma concentration-time curve, Maximum plasma concentration and 1 more. Status: unknown.
02
Drugs
andrographis paniculata
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04161404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04161404.